Maribavir Antiviral Drug Patent, Five Inventors, Filed 2025
Summary
Maribavir Antiviral Drug Patent, Five Inventors, Filed 2025
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
Application US20260097018A1 Kind: A1 Apr 09, 2026
Inventors
Jeffrey Scott DEPUE, Suresh Kumar TIPPARAJU, Helge Alfred REISCH, Datong TANG, Kishore RAMACHANDRAN
Abstract
The present disclosure discloses compositions comprising maribavir, methods of providing the same, and compositions providing intermediates useful in providing maribavir.
CPC Classifications
A61K 31/4184 A61K 9/0053 A61K 31/7056 C07H 19/052
Filing Date
2025-11-21
Application No.
19396651
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.